Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sentinel Lymph Node Mapping Post-Injection Site Pain

This study has been completed.
Navidea Biopharmaceuticals
Information provided by (Responsible Party):
Anne Wallace, MD, University of California, San Diego Identifier:
First received: February 13, 2014
Last updated: July 23, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)